Angiotensinogen gene T235 variant: a marker for the development of persistent microalbuminuria in children and adolescents with type 1 diabetes mellitus

Journal of Diabetes and its Complications

Volumn 22, Issue 3, 2008, Pages 191-198

  Gallego, Patricia H ^a   Shephard, Neil ^b   Bulsara, Max K ^c,d   van Bockxmeer, Frank M ^c,e   Powell, Brenda L ^b   Beilby, John P ^e   Arscott, Gillian ^e   Le Page, Michael ^a   Palmer, Lyle J ^b   Davis, Elizabeth A ^a,d   Jones, Timothy W ^a,d   Choong, Catherine S Y ^a,d  

^a PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

Albumin excretion rate; Microalbuminuria; Nephropathy; Renin angiotensin system; Type 1 diabetes mellitus

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE;

ADOLESCENT; ADULT; ARTICLE; DISEASE COURSE; DISEASE DURATION; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK ASSESSMENT; URINALYSIS;

ADOLESCENT; ALBUMINURIA; ANGIOTENSINOGEN; AUSTRALIA; CHILD; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DNA PRIMERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC MARKERS; GENOTYPE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RENIN-ANGIOTENSIN SYSTEM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VARIATION (GENETICS);

EID: 42249109982     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2007.03.003     Document Type: Article

References (51)

1. Abbud A.Z., Wilson C.A., Cosgrove M.N., and Kostis B.J. Angiotensin-converting enzyme gene polymorphism in systemic hypertension. American Journal of Cardiology 81 2 (1998) 244-246
2. Alsaeid M., Moussa A.M., Haider Z.M., Refai M.T., Abdella N., Al-Sheikh N., and Gomez E.J. Angiotensin-converting enzyme gene polymorphism and lipid profiles in Kuwaiti children with type 1 diabetes. Pediatric Diabetes 5 2 (2004) 87-94
3. Anderson P.W., Do Y.S., and Hsueh W.A. Angiotensin II causes mesangial cell hypertrophy. Hypertension 21 1 (1993) 29-35
4. Barkai L., Soos A., and Vamosi I. Association of angiotensin-converting enzyme DD genotype with 24-h blood pressure abnormalities in normoalbuminuric children and adolescents with Type 1 diabetes. Diabetic Medicine 22 8 (2005) 1054-1059
5. Bedir A., Arik N., Adam B., Kilinc K., Gumus T., and Guner E. Angiotensin converting enzyme gene polymorphism and activity in Turkish patients with essential hypertension. American Journal of Hypertension 12 10 Pt 1 (1999) 1038-1043
6. Borch-Johnsen K., Andersen P.K., and Deckert T. The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28 8 (1985) 590-596
7. Borch-Johnsen K., Nissen H., Henriksen E., Kreiner S., Salling N., Deckert T., et al. The natural history of insulin-dependent diabetes mellitus in Denmark: 1. Long-term survival with and without late diabetic complications. Diabetic Medicine 4 3 (1987) 201-210
8. Borch-Johnsen K., Norgaard K., Hommel E., Mathiesen E.R., Jensen J.S., Deckert T., and Parving H.H. Is diabetic nephropathy an inherited complication?. Kidney International 41 4 (1992) 719-722
9. Boright A.P., Paterson A.D., Mirea L., Bull S.B., Mowjoodi A., Scherer S.W., and Zinman B. Genetic variation at the ACE gene is associated with persistent microalbuminuria and severe nephropathy in type 1 diabetes: The DCCT/EDIC Genetics Study. Diabetes 54 4 (2005, April) 1238-1244
10. Butler R., Morris D.A., Burchell B., and Struthers D.A. DD angiotensin-converting enzyme gene polymorphism is associated with endothelial dysfunction in normal humans. Hypertension 33 5 (1999) 1164-1168
11. Caulfield M., Lavender P., Farrall M., Munroe P., Lawson M., Turner P., and Clark A.J. Linkage of the angiotensinogen gene to essential hypertension [see comment]. New England Journal of Medicine 330 23 (1994) 1629-1633
12. Chowdhury T.A., Dronsfield M.J., Kumar S., Gough S.L., Gibson S.P., Khatoon A., MacDonald F., Rowe B.R., Dunger D.B., Dean J.D., Davies S.J., Webber J., Smith P.R., Mackin P., Marshall S.M., Adu D., Morris P.J., Todd J.A., Barnett A.H., Boulton A.J., and Bain S.C. Examination of two genetic polymorphisms within the renin-angiotensin system: No evidence for an association with nephropathy in IDDM. Diabetologia 39 9 (1996) 1108-1114
13. Crisan D., and Carr J. Angiotensin I-converting enzyme-Genotype and disease associations. Journal of Molecular Diagnostics 2 3 (2000) 105-115
14. DCCT. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group. Journal of Pediatrics 125 2 (1994) 177-188
15. Doria A., Onuma T., Gearin G., Freire M.B., Warram J.H., and Krolewski A.S. Angiotensinogen polymorphism M235T, hypertension, and nephropathy in insulin-dependent diabetes. Hypertension 27 5 (1996) 1134-1139
16. Doria A., Onuma T., Warram J.H., and Krolewski A.S. Synergistic effect of angiotensin II type 1 receptor genotype and poor glycaemic control on risk of nephropathy in IDDM. Diabetologia 40 11 (1997) 1293-1299
17. Fabris B., Bortoletto M., Candido R., Barbone F., Cattin R.M., Calci M., Scanferla F., Tizzoni L., Giacca M., and Carretta R. Genetic polymorphisms of the renin-angiotensin-aldosterone system and renal insufficiency in essential hypertension. Journal of Hypertension 23 2 (2005) 309-316
18. Falkner B., and Daniels R.S. Summary of the Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents. Hypertension 44 4 (2004) 387-388
19. Feldt-Rasmussen B., Borch-Johnsen K., and Mathiesen R.E. Hypertension in diabetes as related to nephropathy. Early blood pressure changes. Hypertension 7 6 Pt 2 (1985, Nov-Dec) II18-II20
20. Fogarty D.G., Harron J.C., Hughes A.E., Nevin N.C., Doherty C.C., and Maxwell A.P. A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM. Diabetes 45 9 (1996) 1204-1208
21. Freire M.B.S., Ji L., Onuma T., Orban T., Warram J.H., and Krolewski A.S. Gender-specific association of M235T polymorphism in angiotensinogen gene and diabetic nephropathy in NIDDM. Hypertension 31 (1998) 896-899
22. Gallego H.P., Bulsara K.M., Frazer F., Lafferty R.A., Davis A.E., and Jones W.T. Prevalence and risk factors for microalbuminuria in a population-based sample of children and adolescents with T1DM in Western Australia. Pediatric Diabetes 7 (2006) 165-172
23. Gorman D., Sochett E., and Daneman D. The natural history of microalbuminuria in adolescents with type 1 diabetes. Journal of Pediatrics 134 3 (1999) 333-337
24. Haynes A., Bower C., Bulsara K.M., Jones W.T., and Davis A.E. Continued increase in the incidence of childhood Type 1 diabetes in a population-based Australian sample (1985-2002). Diabetologia 47 5 (2004) 866-870
25. Huang X.H., Rantalaiho V., Wirta O., Pasternack A., Koivula T., Hiltunen T.P., Nikari T., and Lehtimaki T. Angiotensin-converting enzyme gene polymorphism is associated with coronary heart disease in non-insulin-dependent diabetic patients evaluated for 9 years. Metabolism, Clinical and Experimental 47 10 (1998) 1258-1262
26. ISPAD. ISPAD consensus guidelines for the management of type 1 diabetes mellitus in children and adolescents. ISPAD-International Society for Pediatric and Adolescent Diabetes (2000) 99-100
27. Jeunemaitre X. Renin-angiotensin-aldosterone system polymorphisms and essential hypertension: Where are we?. Journal of Hypertension 21 12 (2003) 2219-2222
28. Jeunemaitre X., Soubrier F., Kotelevtsev Y.V., Lifton R.P., Williams C.S., Charru A., Hunt S.C., Hopkins P.N., Williams R.R., Lalouel J., and Corvol P. Molecular basis of human hypertension: Role of angiotensinogen. Cell 71 1 (1992) 169-180
29. Kobayashi K., Amemiya S., Mochizuki M., Matsushita K., Sawanobori E., Ishihara T., Higashida K., Shimura Y., Kato K., and Nakazawa S. Association of angiotensin-converting enzyme gene polymorphism with lipid profiles in children and adolescents with insulin-dependent diabetes mellitus. Hormone Research 51 4 (1999) 201-204
30. Mathiesen E.R., Ronn B., Storm B., Foght H., and Deckert T. The natural course of microalbuminuria in insulin-dependent diabetes: A 10-year prospective study. Diabetic Medicine 12 6 (1995) 482-487
31. McCaskie, A. P., Crarker, W. K., & Palmer, J. L. (2006). SimHap: A comprehensive modelling framework and simulation-based approach to haplotypic analysis of population-based data. New beta 2.1 version. http:www.genepi.org.au/simhap.
32. Miller J.A., and Scholey J.W. The impact of renin-angiotensin system polymorphisms on physiological and pathophysiological processes in humans. Current Opinion in Nephrology and Hypertension 13 1 (2004) 101-106
33. Miller J.A., Thai K., and Scholey J.W. Angiotensin II type 1 receptor gene polymorphism and the response to hyperglycemia in early type 1 diabetes. Diabetes 49 9 (2000) 1585-1589
34. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research 16 3 (1988) 1215
35. Ng D.P.K., Tai B.C., Koh D., Tan K.W., and Chia K. Angiotensin-I converting enzyme insertion/deletion polymorphism and its association with diabetic nephropathy: A meta-analysis of studies reported between 1994 and 2004 and comprising 14,727 subjects. Diabetologia 48 (2005) 1008-1016
36. Pasquale D.P., Cannizzaro S., and Paterna S. Does angiotensin-converting enzyme gene polymorphism affect blood pressure? Findings after 6 years of follow-up in healthy subjects. European Journal of Heart Failure 6 1 (2004) 11-16
37. Pavlovic M., Holl W.R., Haeberle U., Schwarz K., Heinze E., Debatin M.K., and Lang D. Angiotensin I converting enzyme and angiotensinogen gene polymorphisms related to 24-h blood pressure in paediatric type I diabetes mellitus. European Journal of Pediatrics 158 1 (1999) 18-23
38. Pavlovic M., Reile M., Haeberle U., Schwarz K., Heinze E., Teller W., Lang D., and Holl R.W. Angiotensin I-converting enzyme-gene-polymorphism: Relationship to albumin excretion and blood pressure in pediatric patients with type-I-diabetes mellitus. Experimental and Clinical Endocrinology & Diabetes 105 5 (1997) 248-253
39. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., and Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. Journal of Clinical Investigation 86 4 (1990) 1343-1346
40. Rogus J.J., Moczulski D., Freire M.B., Yang Y., Warram J.H., and Krolewski A.S. Diabetic nephropathy is associated with AGT polymorphism T235: Results of a family-based study. Hypertension 31 2 (1998) 627-631
41. Tarnow L., Cambien F., Rossing P., Nielsen F.S., Hansen B.V., Ricard S., Poirer O., and Parving H.H. Angiotensin-II type 1 receptor gene polymorphism and diabetic microangiopathy. Nephrology Dialysis Transplantation 11 6 (1996) 1019-1023
42. Tarnow L., Cambien F., Rossing P., Nielsen F.S., Hansen B.V., Ricard S., Poirier O., and Parving H.H. Angiotensinogen gene polymorphisms in IDDM patients with diabetic nephropathy. Diabetes 45 3 (1996) 367-369
43. Tarnow L., Kjeld T., Knudsen E., Major-Pedersen A., and Parving H.H. Lack of synergism between long-term poor glycaemic control and three gene polymorphisms of the renin angiotensin system on risk of developing diabetic nephropathy in type I diabetic patients. Diabetologia 43 6 (2000) 794-799
44. Teranishi M., Ono H., Ishimitsu T., and Matsuoka H. Insertion/deletion angiotensin converting enzyme gene polymorphism affects the microvascular structure of the kidney in patients with nondiabetic renal disease. Journal of Hypertension 17 3 (1999) 351-356
45. Thomas W., Shen Y., Molitch M.E., and Steffes M.W. Rise in albuminuria and blood pressure in patients who progressed to diabetic nephropathy in the Diabetes Control and Complications Trial. Journal of the American Society of Nephrology 12 2 (2001) 333-340
46. van Bockxmeer F.M., Mamotte D.C., Burke V., and Taylor R.R. Angiotensin-converting enzyme gene polymorphism and premature coronary heart disease. Clinical Science 99 3 (2000) 247-251
47. van Ittersum F.J., de Man A.M., Thijssen S., de Knijff P., Slagboom E., Smulders Y., Tarnow L., Donker A.J., Bilo H.J., and Stehouwer C.D. Genetic polymorphisms of the renin-angiotensin system and complications of insulin-dependent diabetes mellitus. Nephrology Dialysis Transplantation 15 7 (2000) 1000-1007
48. Vidmar S., Carlin J., Hesketh K., and Cole T. Standardizing anthropometric measures in children and adolescents with new functions for egen. Stata Journal 4 1 (2004) 1-6
49. Winkelmann R.B., Russ P.A., Nauck M., Klein B., Bohm B.O., Maier V., Zotz R., Matheis G., Wolf A., and Wieland H. Angiotensinogen M235T polymorphism is associated with plasma angiotensinogen and cardiovascular disease. American Heart Journal 137 4 (1999) 698-705
50. Ye S., Dhillon S., Ke X., Collins A.R., and Day I.N. An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Research 29 17 (2001) E88-8
51. Yip W.J., Jones L.S., Wiseman J.M., Hill C., and Viberti G. Glomerular hyperfiltration in the prediction of nephropathy in IDDM: A 10-year follow-up study. Diabetes 45 12 (1996) 1729-1733